Gentian Diagnostics ASA (OSL: GENT)
Norway
· Delayed Price · Currency is NOK
40.00
-0.20 (-0.50%)
Dec 27, 2024, 4:25 PM CET
Gentian Diagnostics ASA Revenue
Gentian Diagnostics ASA had revenue of 32.70M NOK in the quarter ending September 30, 2024, with 1.96% growth. This brings the company's revenue in the last twelve months to 154.12M, up 19.88% year-over-year. In the year 2023, Gentian Diagnostics ASA had annual revenue of 142.35M with 27.18% growth.
Revenue (ttm)
154.12M
Revenue Growth
+19.88%
P/S Ratio
4.00
Revenue / Employee
2.66M
Employees
58
Market Cap
616.89M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 142.35M | 30.42M | 27.18% |
Dec 31, 2022 | 111.92M | 11.91M | 11.91% |
Dec 31, 2021 | 100.01M | 21.13M | 26.78% |
Dec 31, 2020 | 78.88M | 23.50M | 42.43% |
Dec 31, 2019 | 55.38M | 9.56M | 20.87% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 513.12M |
Medistim ASA | 541.82M |
Photocure ASA | 526.25M |
Carasent ASA | 264.80M |
Nykode Therapeutics AS | 46.02M |
ArcticZymes Technologies ASA | 110.76M |
Hofseth BioCare ASA | 248.08M |
Navamedic ASA | 525.55M |